Crossmark

Corticosteroids in the treatment of IgA nephropathy: lessons from the TESTING trial

Published Online: 2023-03-07

Published Print: 2023-10

Authors

Zhang, Yuemiao https://orcid.org/0000-0001-9863-4738
Hu, Yi-Tong

Lv, Ji-Cheng

Zhang, Hong
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82170711, 82070733)

Peking University Medicine Seed Fund for Interdisciplinary Research (BMU2022MX025)

the National High Level Hospital Clinical Research Funding (2022CR81)

the Fundamental Reserach Funds for the Central Universities

the PRORUN fund of the nephrology group of CEBM (KYS2021-03-02-16)

CAMS Innovation Fund for Medical Sciences (2019-I2M-5-046)
License Information

Text and Data Mining valid from 2023-03-07

Version of Record valid from 2023-03-07
More Information

Article History

Received: 10 October 2022

Revised: 22 January 2023

Accepted: 14 February 2023

First Online: 7 March 2023

Declarations

:

: The authors declare no competing interests.

Document is current